Literature DB >> 27171208

Progress Toward Polio Eradication - Worldwide, 2015-2016.

Michelle Morales, Rudolf H Tangermann, Steven G F Wassilak.   

Abstract

In 1988, the World Health Assembly resolved to eradicate poliomyelitis. Wild poliovirus (WPV) transmission persists in only two countries (Afghanistan and Pakistan) after the removal of Nigeria from the list of countries with endemic polio in September 2015.* Indigenous WPV type 2 has not been detected since 1999 and was declared eradicated by the Global Commission for the Certification of Poliomyelitis Eradication in September 2015.(†) Since November 2012, when the last case of WPV type 3 was detected in Nigeria, WPV type 1 has been the sole circulating type of WPV (1). This report summarizes global progress toward polio eradication during 2015-2016 and updates previous reports (2). In 2015, 74 WPV cases were reported in two countries (Afghanistan and Pakistan), a decrease of 79% from the 359 WPV cases reported in 2014 in nine countries; 12 WPV cases have been reported in 2016 (to date), compared with 23 during the same period in 2015 (3). Paralytic polio caused by circulating vaccine-derived poliovirus (cVDPV) remains a risk in areas with low oral poliovirus vaccine (OPV) coverage. Seven countries, including Pakistan, reported 32 cVDPV cases in 2015 (4). In four of these countries, ≥6 months have passed since the most recent case or isolate. One country (Laos) with VDPV transmission in 2015 has reported three additional cVDPV cases in 2016 to date. Encouraging progress toward polio eradication has been made over the last year; however, interruption of WPV transmission will require focus on reaching and vaccinating every missed child through high quality supplementary immunization activities (SIAs) and cross-border coordination between Afghanistan and Pakistan (5,6).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27171208     DOI: 10.15585/mmwr.mm6518a4

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  49 in total

1.  Simply put: Vaccination saves lives.

Authors:  Walter A Orenstein; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

Review 2.  Clearing Vaccine-Derived Poliovirus Infection Following Hematopoietic Stem Cell Transplantation: a Case Report and Review of Literature.

Authors:  Mohammadreza Shaghaghi; Mona Irannejad; Hassan Abolhassani; Shohreh Shahmahmoodi; Amir Ali Hamidieh; Saeed Soleyman-Jahi; Reza Yazdani; Gholamreza Azizi; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2018-06-14       Impact factor: 8.317

Review 3.  Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

Authors:  Laura Pöyhönen; Jacinta Bustamante; Jean-Laurent Casanova; Emmanuelle Jouanguy; Qian Zhang
Journal:  J Clin Immunol       Date:  2019-05-23       Impact factor: 8.317

4.  Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.

Authors:  Jingjun Qiu; Yunkai Yang; Lirong Huang; Ling Wang; Zhiwei Jiang; Jian Gong; Wei Wang; Hongyan Wang; Shaohong Guo; Chanjuan Li; Shuyuan Wei; Zhaojun Mo; Jielai Xia
Journal:  Hum Vaccin Immunother       Date:  2017-03-01       Impact factor: 3.452

5.  Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.

Authors:  Jing Shaw; Jaume Jorba; Kun Zhao; Jane Iber; Qi Chen; Festus Adu; Adekunle Adeniji; David Bukbuk; Marycelin Baba; Elizabeth Henderson; Naomi Dybdahl-Sissoko; Sharla McDonald; William C Weldon; Nicksy Gumede; M Steven Oberste; Olen M Kew; Cara C Burns
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

6.  Serological Monitoring Is Key To Sustain Progress of the Maternal and Neonatal Tetanus Elimination Initiative.

Authors:  Myron M Levine; Marcela F Pasetti
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

7.  Thin silk fibroin films as a dried format for temperature stabilization of inactivated polio vaccine.

Authors:  Jordan A Stinson; Carter R Palmer; David P Miller; Adrian B Li; Kandice Lightner; Heather Jost; William C Weldon; M Steven Oberste; Jonathan A Kluge; Kathryn M Kosuda
Journal:  Vaccine       Date:  2020-01-17       Impact factor: 3.641

Review 8.  Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.

Authors:  P L Lopalco
Journal:  Epidemiol Infect       Date:  2016-11-21       Impact factor: 4.434

9.  Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015-2016.

Authors:  Imtiaz Hussain; Ondrej Mach; Atif Habib; Zaid Bhatti; Zamir Suhag; M Steven Oberste; William C Weldon; Roland W Sutter; Sajid B Soofi; Zulfiqar A Bhutta
Journal:  Pediatr Infect Dis J       Date:  2017-09       Impact factor: 3.806

10.  Expression and purification of polioviral proteins in E. coli, and production of antisera as reagents for immunological assays.

Authors:  Madala Uma; P P Rao; K Nagalekshmi; N R Hegde
Journal:  Protein Expr Purif       Date:  2016-08-24       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.